|
DOLPP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.016200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.358400E-01 |
| Normal-vs-Stage2 |
6.809600E-01 |
| Normal-vs-Stage3 |
9.374600E-01 |
| Normal-vs-Stage4 |
7.446400E-01 |
| Stage1-vs-Stage2 |
9.162600E-01 |
| Stage1-vs-Stage3 |
6.339800E-01 |
| Stage1-vs-Stage4 |
4.160800E-01 |
| Stage2-vs-Stage3 |
8.153800E-01 |
| Stage2-vs-Stage4 |
5.736600E-01 |
| Stage3-vs-Stage4 |
7.258000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.195200E-01 |
| Normal-vs-AfricanAmerican |
3.407400E-01 |
| Normal-vs-Asian |
2.960800E-01 |
| Caucasian-vs-AfricanAmerican |
3.637800E-01 |
| Caucasian-vs-Asian |
2.493800E-01 |
| AfricanAmerican-vs-Asian |
3.790400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.917000E-01 |
| Normal-vs-Female |
3.329600E-01 |
| Male-vs-Female |
2.208800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.288000E-01 |
| Normal-vs-Extreme_Weight |
8.568200E-01 |
| Normal-vs-Obese |
7.812600E-01 |
| Normal-vs-Extreme_Obese |
8.997000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.001600E-01 |
| Normal_Weight-vs-Obese |
6.302600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.551400E-01 |
| Extreme_Weight-vs-Obese |
8.995000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.690400E-01 |
| Obese-vs-Extreme_Obese |
9.786800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.899000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.695640E-01 |
| Normal-vs-Age(61-80Yrs) |
1.277400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.841600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.857800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.575800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.531200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.302000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.857400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.263600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.120000E-01 |
| Normal-VS-Type2 PRCC |
2.460200E-01 |
| Normal-VS-KIRP CIMP |
3.292600E-01 |
| Normal-VS-Unclassified PRCC |
5.680200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.840160E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.176180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.392990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.835600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.846400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.975800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.025600E-01 |
| Normal-vs-N1 |
5.040200E-01 |
| Normal-vs-N2 |
5.339400E-01 |
| N0-vs-N1 |
6.738400E-01 |
| N0-vs-N2 |
5.800600E-01 |
| N1-vs-N2 |
7.284800E-01 |
|
|
